TEVAPIRIN

Kraj: Izrael

Język: angielski

Źródło: Ministry of Health

Kup teraz

Składnik aktywny:

ACETYLSALICYLIC ACID

Dostępny od:

TEVA ISRAEL LTD

Kod ATC:

B01AC06

Forma farmaceutyczna:

TABLETS ENTERIC COATED

Skład:

ACETYLSALICYLIC ACID 100 MG

Droga podania:

PER OS

Typ recepty:

Not required

Wyprodukowano przez:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Dziedzina terapeutyczna:

ACETYLSALICYLIC ACID

Wskazania:

The primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

Data autoryzacji:

2020-08-31

Ulotka dla pacjenta

                                TEVAP ECTAB PL SH 311220
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed without a doctor’s prescription
TEVAPIRIN
®
ENTERIC-COATED TABLETS
100 MG
COMPOSITION:
Each film-coated tablet contains:
Acetylsalicylic acid 100 mg
For information on inactive ingredients, see section 6 – “Further
Information”.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE.
This leaflet contains concise information about the medicine. If you
have
further questions, refer to the doctor or pharmacist.
Take the preparation according to the instructions in section 3 in
this
leaflet. Consult the pharmacist if you need further information.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for primary prevention of coronary heart
disease in high-risk patients and secondary prevention of thrombotic
cardiovascular and cerebrovascular diseases.
THERAPEUTIC GROUP: Anticoagulants, blood platelet aggregation
inhibitors.
Tevapirin inhibits the aggregation of blood platelets and in this way
prevents
blood clots from developing.
2. BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
- You are sensitive (allergic) to acetylsalicylic acid, salicylates,
or to
any of the other ingredients contained in the medicine (for a list of
the inactive ingredients, see section 6 – “Further
Information”).
- You have had in the past a reaction to certain medicines against
pain, fever or inflammation (salicylates or other nonsteroidal anti-
inflammatory medicines), manifested by asthma attacks or other
allergic reactions.
- You suffer from acute gastric or intestinal ulcers.
- You have a tendency to disorders that cause bleeding.
- You suffer from kidney or liver failure.
- You suffer from severe heart failure that is not being treated
properly.
- You are concurrently taking methotrexate at a dosage of 15 mg or
more per week.
- You are in the last trimester of pregnancy, and are taking a daily
dosage
exceeding 150 mg (see section “Pregnancy and b
                                
                                Przeczytaj cały dokument
                                
                            

Dokumenty w innych językach

Ulotka dla pacjenta Ulotka dla pacjenta arabski 25-04-2022
Ulotka dla pacjenta Ulotka dla pacjenta hebrajski 28-02-2022

Wyszukaj powiadomienia związane z tym produktem

Zobacz historię dokumentów